MENU
APLS
AS OF
Nov 20, 04:59 PM (EDT)
Price
$19.55
Change
+$0.10 (+0.51%)
Capitalization
2.47B
104 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
APLS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Apellis Pharmaceuticals (APLS) Ownership - Who owns Apellis Pharmaceuticals?

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Medical Distributors
Address
100 Fifth Avenue
Phone
+1 617 977-5700
Employees
706
Web
https://www.apellis.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.47B
P/E Ratio
54.28
Total Cash
479.17M
Projected Growth
N/A
Total Debt
475.37M
Revenue
1.02B
Risk (Beta)
-0.23
Dividend Yield
N/A
Total Cash/Share
3.79
Total Debt/Equity
N/A
Revenue/Share
7.92 USD as % of share price

Fundamentals

APLS
Capitalization
2.47B
P/E Ratio
54.28
Risk (Beta)
-0.23
Dividend Yield
N/A
Total Cash
479M
Total Cash/Share
3.79
Total Debt
475M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
7.92%
Revenue
1.02B
ROE
N/A
Book Value
401M
P/B Ratio
6.16
Cash Flow
N/A
Earnings
0.36
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
12K
Current Ratio
3.54
Current Revenue Per Employee
645884.50
Dividends Per Share - Security
N/A
EBITDA
93.4M
Float
N/A
Float - Current
N/A
Gross Income Margin
94.65
Revenue To Assets
4.59
Shares Held By Institutions
5.21B
Shares Outstanding - Current
127M
Total Liabilities
658M
Total Volume MTD
N/A
Value
-1
Gain YTD
-39.032
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
APLS
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. APLS showed earnings on October 30, 2025. You can read more about the earnings report here.
View AI-Driven Trading for APLS
A.I. Advisor
published General Information

General Information

a developer of therapeutics and drug delivery technologies to address chronic inflammatory diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Medical Distributors
Address
100 Fifth Avenue
Phone
+1 617 977-5700
Employees
706
Web
https://www.apellis.com